Achieve Life Sciences logo

Achieve Life Sciences (ACHV) Q4 2024 Annual Earnings

ACHV·Reported March 11, 2025·Before market open

Diluted EPS came in at $-0.36, missed the $-0.30 consensus by $0.06.

Diluted EPS
$-0.36missed by $0.06
Consensus: $-0.30
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q4 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q4 2024 Earnings FAQ

Common questions about Achieve Life Sciences's Q4 2024 earnings report.

Achieve Life Sciences (ACHV) reported Q4 2024 earnings on March 11, 2025 before market open.

Achieve Life Sciences reported diluted EPS of $-0.36 for Q4 2024.

EPS missed the consensus estimate of $-0.30 by $0.06.

You can read the 10-K periodic report (0000950170-25-036831) directly on SEC EDGAR. The filing index links above go to sec.gov.